Background
==========

Individuals with type 2 diabetes mellitus (T2DM) are routinely advised about the importance of physical activity (PA) for controlling risk factors associated with disease progression \[[@B1],[@B2]\]. PA positively affects glycaemic control in individuals with established T2DM \[[@B3]-[@B5]\] and as part of multifactorial interventions, is associated with significant improvements in blood pressure, cholesterol, weight loss and fitness \[[@B6]\]. Less is known regarding the effectiveness of PA interventions adopted early in the disease trajectory, for example following screen-detection \[[@B7]\]. Recently diagnosed T2DM patients represent a group of individuals with high, but modifiable cardiovascular risk \[[@B8]\]. It is plausible that building or reinforcing good PA habits early in the disease trajectory may help prevent or delay complications associated with T2DM.

Evidence suggests that recently diagnosed T2DM patients and those at high risk of T2DM have low PA levels, but data is limited \[[@B7],[@B9],[@B10]\]. In addition, poor recognition of PA inactivity may act as a barrier to healthy behaviour change in these individuals. For example, individuals who overestimate their PA activity are less likely to perceive a need to change their PA behaviour and may be unreceptive to health promotion interventions. Previous studies assessing PA awareness -- in terms of the difference between an individual's belief of meeting PA guidelines versus measured PA levels -- report that between 15% and 35% of healthy adults are PA overestimators \[[@B11]-[@B13]\]. One study of individuals at high risk of T2DM objectively classified 63% as inactive, with individuals more likely to be PA overestimators if they were male, had low BMI and were from a low socio-economic background \[[@B14]\]. All previous studies categorise PA awareness and therefore do not fully capture the difference between true- and self reported- PA. Furthermore, most previous studies compared self-reported and self-rated measures of PA behaviour, which could lead to a biased assessment of agreement due to correlated error introduced by using measurement tools of the same fundamental type; an issue explored extensively in nutritional epidemiology \[[@B15],[@B16]\].

Here we aimed to characterise objective PA levels using a combined heart rate and accelerometry monitor, assess the difference between continuously measured objective and self-reported PA and investigate associated characteristics in recently diagnosed T2DM from the *ADDITION-Plus* cohort \[[@B17]\]. We define PA disparity as the non-negative value of the difference (in mathematical terms the absolute difference) between objective and self-reported PAEE. Specifically, we *(i)* describe objectively measured free-living PA; (*ii*) describe PA disparity; (*iii*) examine which individual characteristics -- from a range of socio-demographic, clinical, health behaviour, quality of life and psychological -- are associated with PA disparity; and due to their potential public health importance, (*iv*) examine which characteristics are associated with PA overestimation. This will further our understanding of PA perceptions and may help optimize and target interventions promoting PA in recently diagnosed T2DM patients.

Methods
=======

Study design and population
---------------------------

Full details of the study have been reported \[[@B17]\]. Briefly, *ADDITION-Plus* is a randomised controlled trial nested within the intensive treatment arm of the *ADDITION-Cambridge* study, which evaluated the efficacy of a facilitator-led, theory-based behaviour change intervention for recently diagnosed T2DM patients. Thirty four general practices in East Anglia participated. Eligible individuals were those aged 40 to 69 diagnosed with T2DM following screening or clinically diagnosed in the past 3 years in participating general practices. All participants received advice regarding the importance of a healthy lifestyle, including PA, for the control of diabetes, as well as a target for behaviour change (for PA, a gradual increase to reach the equivalent of 35 minutes of brisk walking per day, 7 days per week). Data were collected between 2003 and 2007 and analyzed in 2012. Exclusion criteria included women who were pregnant/lactating, those suffering from a psychotic illness or those with a prognosis of less than one year. Out of 1109 eligible participants, 478 agreed to participate in *ADDITION-Plus* and were individually randomised to receive either intensive treatment alone (n = 239), or intensive treatment plus the facilitator-led individual behaviour change intervention (n = 239) \[[@B17]\]. One year follow-up data was used in these analyses and health assessments at one year included physiological and clinical measurements, venesection by trained staff following standard operating procedures and the self-completion of questionnaires. Ethical approval was obtained from the Eastern Multi-Centre Research Ethics Committee (reference number: 02/5/54). Participants gave written informed consent. The trial is registered as ISRCTN 99175498.

Outcome measurement
-------------------

Both our objective and self-reported physical activity assessments capture total habitual physical activity. Free-living PA was objectively measured using a combined heart rate (HR) and accelerometry (ACC) monitor (Actiheart, CamNtech, Papworth, UK), worn continuously for 4 days \[[@B18]\]. This objective measure of physical activity was only available at one year of follow-up. Where possible, individual HR calibration was completed using a 15-minute graded-treadmill walk calibration \[[@B19]\]. A robust Gaussian process model inferred the latent HR time-series \[[@B20]\] and activity intensity (J · min^-1^ · kg^-1^) was estimated using a branched equation framework \[[@B21]\]. Resulting time-series data were summarised into mean physical activity energy expenditure over 24-hours (PAEE in kJ · kg^-1^ ·day^-1^). Where individual calibration measures were unavailable (n = 61), calibration of HR was derived across all valid study calibration tests using age, sex, beta blockage, and sleeping HR as pseudo-individual calibration.

The previously validated short European Prospective Investigation into Cancer and Nutrition \[EPIC\]-Norfolk Physical Activity Questionnaire \[EPAQ2\] was used to measure self-reported past-year PA across four different domains (recreational, home activities, commuting/travel and occupational PA) \[[@B22]\]. Net Activity MET hrs · day^-1^ was computed by multiplying activity duration by the metabolic cost of each activity (activity-specific MET) \[[@B23],[@B24]\], while discounting the resting metabolic rate. Daily PAEE estimates were derived from self-reported Net Activity MET hrs · day^-1^ using a method similar to that previously published \[[@B25],[@B26]\], using \[(1440 min·day^-1^) x (reported non-sedentary time/reported awake time)\] as the scaling factor for average intensity. The difference between objective and self-reported PAEE (PA difference) was calculated for each individual (and can have positive or negative values, Figure [1](#F1){ref-type="fig"}A & B). The PAEE equivalent to 30 minutes of moderate activity was calculated as 4.91 kJ · kg^-1^· day^-1^ (MET equivalent of 3.3 METs for moderate walking at 3 miles · hr^-1^\[[@B23]\]) and was used to define a 'PA Aware' zone that included PA difference values falling within 4.91 kJ · kg^-1^· day^-1^ of zero (Figure [1](#F1){ref-type="fig"}A & B). Thus 'overestimators' comprised those whose self-reported exceeded their objective PAEE by 4.91 kJ · kg^-1^· day^-1^ and 'underestimators' comprised those whose objective exceeded their self-reported PAEE by 4.91 kJ · kg^-1^· day^-1^. 'PA disparity' was defined as the absolute difference between objective and self-reported PAEE. Individuals with missing self-reported or objective PA data (n = 51) and extreme PA disparity outliers (values \>4 times the SD: n = 2), were not included in these analyses.

![**Distribution of physical activity difference.** The difference between objective minus self-reported physical activity energy expenditure (PA difference) in recently diagnosed **(A)** female and **(B)** male T2DM patients is presented. Data were collected in Eastern England, UK between 2003 and 2007 (*ADDITION-Plus* study).](1471-2458-13-678-1){#F1}

Explanatory variables and covariates
------------------------------------

Body height and weight were measured in individuals in light clothing, without shoes, using a fixed rigid stadiometer and scale (SECA, UK). A BMI greater than or equal to 25 or 30 kg/m^2^ defined overweight and obese, respectively \[[@B27]\]. Waist circumference was estimated as the average of two measurements taken with a tape measure halfway between the rib cage lowest point and the anterior superior iliac crests. HbA~1c~ was analysed in venous samples by ion-exchange high-performance liquid chromatography (Tosoh Bioscience, Redditch, UK). Total cholesterol was measured using standard enzymatic techniques \[[@B17]\]. Blood pressure was calculated as the mean of three automatic sphygmomanometer (Omron M4, UK) measurements performed after at least 10 minutes rest with participants seated and the cuff at heart level on the dominant arm.

Standardised questionnaires collected information on socio-demographic characteristics and lifestyle habits (smoking status, alcohol consumption). Socio-economic categories were based on the National Statistics Socio-Economic Classification (NS-SEC) and comprised: *(i)* managerial/professional; *(ii)* intermediate or *(iii)* routine/manual occupations based on current or previous occupation. A validated FFQ was used to estimate daily dietary intake \[[@B28]\]. The EuroQol (EQ-5D) measured health utility and health-related quality of life (QoL) \[[@B29],[@B30]\]. The Audit of Diabetes-Dependent QoL (ADDQoL) measured respondents' perceptions of the impact of T2DM on their QoL \[[@B31]\]. The generic Short Form 36-item (SF-36) Health Survey measured general health utility \[[@B32]\]. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) measured treatment satisfaction \[[@B33]\]. The *ADDITION-Plus* lifestyle behaviour change questionnaire included selected cognitions about becoming more physically active \[[@B34],[@B35]\]. The questionnaire included two items to assess perceived behavioural control and intention to become more physically active \[[@B36]\].

Statistical analyses
--------------------

Participant characteristics were summarised using means (SD) and percentages. Differences between individuals with and without both self-reported and objective PA data were assessed using t-tests. Univariable linear regression was used to examine the association between PA disparity and socio-demographic, clinical, health behaviour, QoL and psychological characteristics. Beginning with the variable most strongly associated with PA disparity in univariable models, a multivariable model was built via stepwise forward regression. Likelihood ratio tests (LRT) compared models with and without each potential predictor variable and this process was repeated until no new variable improved model fit. Sex, age and trial arm were considered *a priori* confounders and included in all models. A binary 'PA overestimation' variable was generated (PA overestimators = 1, PA aware + PA underestimators = 0) and logistic regression was used to examine the association between overestimators and individual characteristics. Correlation coefficients between socio-demographic, health behaviour, clinical, QoL and psychological variables were all *r* ≤ 0.34 and variance inflation factors (VIF) were all ≤4.2. As beta-blocker use and insufficient continuous monitoring of objective PA can affect PAEE estimates, sensitivity analyses were conducted excluding the following individuals: (*i*) 6 participants who wore the Actiheart for less than 48 hours and (*ii*) 103 participants who reported taking beta-blockers. Additionally, as Occupational MET is a key determinant of self-reported PA, \[[@B37]\] sensitivity analyses were carried out which (*iii*) assigned lower MET values to occupational categories; specifically, occupational MET values \> 1 were rescaled by 0.75 providing more conservative estimates of activity-specific occupational MET and hence, self-reported Net Activity MET hrs · day^-1^. Finally, to examine if differences in the time frames captured between self-report and objective methods (5 days versus 12 months, respectively) effect validity, (*iv*) one individual from each season (in which objective PA was measured) was randomly selected to form groups of four (n = 100 draws) and between-group correlations were compared with individual-level correlations using random effects regression. Statistical significance was set at a level of *p* \< 0.05. All analyses were performed using Stata version 11.2 (Statacorp. College Station, Texas).

Results
=======

Descriptive characteristics and physical activity levels of participants
------------------------------------------------------------------------

Characteristics of *ADDITION-Plus* participants with complete PA data for analysis (n = 425) are presented in Table [1](#T1){ref-type="table"}. Individuals without PA data at one-year were similar to those with complete data for age, sex, socio-economic status and ethnicity (data not shown). The mean (SD) age of participants was 60.3 (7.5) years. The majority of participants were male (63%), Caucasian (97%) and were in managerial/professional or intermediate occupations (41% and 25%, respectively) (Table [1](#T1){ref-type="table"}). The majority of participants were overweight (33%) or obese (62%). In just under half of participants (48%, n = 202), mean HbA~1c~ levels were below 6.5% and 78.5% (n = 333) had total cholesterol levels below 5 mmol/l.

###### 

**Descriptive characteristics and physical activity levels at 1 year follow-up in the*ADDITION-Plus*cohort, UK, 2003 to 2007**

  **Characteristic**                   **Variable**                    **Category/scale, units**   **N**           **Mean (SD)**
  ------------------------------------ ------------------------------- --------------------------- --------------- ---------------
  Socio-demographic                    Sex                             \% Male                     425             62.6 (266)^a^
  Age category                         42--54.9, years                 92                          21.6 (92)^a^    
                                       55--59.9                        90                          21.2 (90)^a^    
                                       60--64.9                        81                          19.1 (81)^a^    
                                       65--71                          162                         38.1 (162)^a^   
  Ethnicity                            \% Caucasian                    425                         97.4 (414)^a^   
  Socio-economic category              Managerial/professional         171                         40.7 (171)^a^   
                                       Intermediate                    104                         24.8 (104)^a^   
                                       Routine/manual                  145                         34.5 (145)^a^   
  Clinical                             BMI                             Male, kg/m^2^               264             31.7 (5.1)
                                       Female, kg/m^2^                 159                         33.0 (6.0)      
  Waist circumference                  Male, cm                        235                         111.9 (13.6)    
                                       Female, cm                      148                         105.1 (13.1)    
  Biochemical                          HbA~1C~                         \%                          423             6.7 (0.9)
  Total cholesterol                    mmol/l                          424                         4.3 (0.9)       
  Systolic blood pressure              mmHg                            423                         129.9 (17.3)    
  Diastolic blood pressure             mmHg                            423                         76.3 (9.2)      
  Physical activity                    Objective PAEE                  kJ · kg^-1^ · day^-1^       425             34.4 (17.0)
                                       Male, kJ · kg^-1^ · day^-1^     266                         37.6 (18.0)     
                                       Female, kJ · kg^-1^ · day^-1^   159                         29.0 (13.6)     
  Self-reported Net Activity METS~Q~   hours day^-1^                   425                         12.4 (7.2)      
                                       Male, hours day^-1^             266                         13.3 (7.8)      
                                       Female, hours day^-1^           159                         11.1 (5.6)      
  Self-reported PAEE~Q~                kJ · kg^-1^ · day^-1^           425                         22.6 (19.4)     
                                       Male, kJ · kg^-1^ · day^-1^     266                         23.7 (21.7)     
                                       Female, kJ · kg^-1^ · day^-1^   159                         20.7 (14.6)     
  Health behaviours                    Smoking status at one year      Current                     58              13.7 (58)^a^
                                       Former                          209                         49.4 (209)^a^   
                                       Never                           156                         36.9 (156)^a^   
  Alcohol consumption                  Units · week^-1^                418                         7.5 (10.7)      
  Total energy                         Kcal · day^-1^                  424                         1738 (493.4)    
  Fat                                  g · day^-1^                     424                         59.9 (22.4)     
  Fruit                                g · day^-1^                     409                         310.8 (218.5)   
  Vegetable                            g · day^-1^                     402                         244.9 (138.9)   
  Quality of life & well being         EuroQol EQ-5D                   scale: −0.3 to 1^b^         418             0.8 (0.2)
  ADDQoL                               scale: −9 to 9^c^               423                         0.9 (1.1)       
  SF-36 general health                 scale: 1 to 5^d^                425                         2.9 (0.9)       
  Diabetes treatment satisfaction      scale: 0 to 36^e^               411                         30.4 (5.5)      
  Psychological                        Intention                       scale: 1 to 5^f^            421             3.5 (0.8)
                                       Perceived behavioural control   scale: 1 to 5^f^            421             3.6 (0.9)

^a^ % (number).

^b^ Weighted health state index, where dead = 0 and full health = 1.

^c^ Weighted impact of diabetes index, where −9 = maximum negative and +9 = maximum positive impact.

^d^ General health utility scale ranging from, 1 = excellent to 5 = poor.

^e^ Diabetes treatment satisfaction scale, where 0 = very dissatisfied and 36 = very satisfied.

^f^ 5-point Likert-type agree/disagree scale, where 5 represents highest behaviour change beliefs.

Physical activity energy expenditure
------------------------------------

Median (IQR) reported non-sedentary time/reported awake time was 0.28 (0.19 to 0.37). Mean objective and self-reported PAEE levels were 34.4 ± 17.0 kJ · kg^-1^ · day^-1^ and 22.6 ± 19.4 kJ · kg^-1^ · day^-1^, respectively. Mean objective PAEE levels were on average 8.6 kJ · kg^-1^ · day^-1^ lower in females compared to males (95% CI = 5.3 to 11.8 kJ · kg^-1^ · day^-1^, *p* \< 0.0001) but there was no difference in self-reported PAEE by sex (difference in means = 3.0, 95% CI = 0.8 to 6.9 kJ · kg^-1^ · day^-1^, *p* = 0.10).

Physical (PA) activity disparity
--------------------------------

Mean 'PA difference' (the difference between objective and self-reported PAEE) was on average lower in females than males (Figure [1](#F1){ref-type="fig"}A & B; difference in means = 5.5, 95% CI = 1.3 to 9.8 kJ · kg^-1^ · day^-1^, *p* \< 0.05). Of the 425 participants, 14% (n = 59) fell within the 'PA Agreement' zone, 19% (n = 80) were overestimators and 67% (n = 286) were underestimators (Figure [1](#F1){ref-type="fig"}A & B). The proportion of individuals in the three awareness zones (over- and under-estimator and aware) did not differ significantly by trial arm (χ^2^ = 4.5, *p* = 0.11). Mean objective PAEE levels were significantly higher in PA underestimators compared to PA overestimators or aware (PAEE in kJ · kg^-1^ · day^-1^ for underestimators: 39.9 ± 17.1 1; overestimators: 27.5 ± 15.1; aware: 25.2 ± 11.5; Bonferroni-adjusted pair-wise comparisons, both *p* \< 0.0001). 'PA disparity' (the absolute difference between objective and self-reported PAEE) captures the magnitude of the difference between the two PA measurements and did not differ between trial arms (difference between mean PA disparity: 1.62 (1.43) kJ · kg^-1^ · day^-1^, t = 1.13, *p* = 0.26). As reported for PA difference, PA disparity was lower in females than males (difference in means = 7.3, 95% CI = 4.5 to 10.2 kJ · kg^-1^ · day^-1^, *p* \< 0.0001).

Individual characteristics associated with PA disparity
-------------------------------------------------------

In univariable regression analysis male sex and having a routine/manual occupation were positively associated with PA disparity, while older age categories, higher BMI, larger waist circumference and high total daily fruit intake, were inversely associated with PA disparity (Table [2](#T2){ref-type="table"}). In multivariable linear regression analysis, men, those in younger age categories, from routine/manual occupations and with lower BMI were more likely to have higher PA disparity (Table [2](#T2){ref-type="table"}). Evidence of a linear trend for age and socio-economic status was found, with PA disparity increasing (i.e. a larger difference between objective and self-reported PAEE) from older to younger age classes and from managerial/professional occupations through to routine/manual occupations (LRT of departure from linear trend, *p* \> 0.05 in both cases).

###### 

**Association between physical activity disparity and socio-demographic, clinical and health behaviour, quality of life and psychological characteristics in the*ADDITION-Plus*cohort, 2003 to 2007**

                                       **Univariable**^**a**^            **Multivariable**^**b**^                                                                       
  ------------------------------------ -------------------------------- -------------------------- ---------------------------- -------- ----- ------------------------ --------
  **Socio-demographic**                                                                                                                                                  
  Sex                                  ♀ = 0, ♂ = 1                                425             7.05 (4.24 to 9.87)          0.0001    402  6.45 (3.49 to 9.41)      0.0001
  Age category                         42--54.9, years                             425             1                            0.019     402  1                        0.012
                                       55--59.9                                                    −0.77 (−4.94 to 3.40)                       0.33 (−3.96 to 4.62)      
                                       60--64.9                                                    −2.21 (−6.51 to 2.08)                       −2.23 (−6.74 to 2.28)     
                                       65−71                                                       −5.24 (−8.88 to −1.54)                      −5.34 (−9.34 to −1.34)    
  Ethnicity                            Asian/Black = 0, Caucasian = 1              425             0.77 (−3.97 to 5.41)         0.47                                     
  Socio-economic category              Managerial/professional                     420             1                            0.029     402  1                        0.043
                                       Intermediate                                                1.92 (−1.66 to 5.51)                        1.77 (−1.89 to 5.45)      
                                       Routine/manual                                              3.57 (0.33 to 6.81)                         4.19 (0.87 to 7.51)       
  **Clinical**                                                                                                                                                           
  BMI                                  kg/m^2^                                     423             −0.31 (−0.56 to −0.061)      0.014     402  −0.39 (−0.65 to −0.13)   0.003
  Waist circumference                  cm                                          425             −0.10 (−0.21 to 0.0008)      0.05                                     
  **Health behaviours**                                                                                                                                                  
  Current smoking status               Current                                      58             1                            0.63                                     
                                       Former                                      209             2.07 (−2.13 to 6.28)                                                  
                                       Never                                       156             1.61 (−2.75 to 5.98)                                                  
  Alcohol consumption                  Units · week^-1^                            418             0.004 (−0.13 to 0.14)        0.95                                     
  Dietary intake                       Total energy, Kcal · day^-1^                424             0.001( −0.0018 to 0.0039)    0.46                                     
                                       Fat, g · day^-1^                            424             0.041 (−0.021 to 0.10)       0.19                                     
                                       Fruit, g · day^-1^                          409             −0.0074 (−0.014 to −0.001)   0.021                                    
                                       Vegetable, g · day^-1^                      402             0.0039 (−0.0065 to 0.014)    0.46                                     
  **Quality of life and well being**                                                                                                                                     
  EuroQol EQ-5D                        scale, −0.3 to 1^c^                         418             1.88 (−4.49 to 8.24)         0.56                                     
  ADDQoL                               scale, −9 to 9^d^                           423             0.16 (−1.03 to 1.35)         0.79                                     
  SF-36 general health                 scale, 1 to 5^e^                            425             −0.13 ( −1.67 to 1.41)       0.86                                     
  Diabetes treatment satisfaction      scale, 0 to 36^f^                           411             0.071 (−0.18 to 0.32)        0.58                                     
  **Psychological**                                                                                                                                                      
  Intention                            scale, 1 to 5^g^                            421             −0.66 (−2.42 to 1.09)        0.45                                     
  Perceived behavioural control        scale, 1 to 5^g^                            421             0.19 (−1.38 to 1.78)         0.80                                     

Output is taken from linear regression models with PA disparity as the outcome variable.

^a^ Adjusted for the *a priori* confounders sex, age and trial arm.

^b^ Adjusted for sex, age, trial arm, socio-economic category and BMI.

^c^ Weighted health state index, where dead = 0 & full health = 1.

^d^ Weighted impact of diabetes index, where −9 = maximum negative and +9 = maximum positive diabetes impact.

^e^ General health utility scale ranging from 1 = excellent to 5 = poor.

^f^ Diabetes treatment satisfaction scale, where 0 = very dissatisfied and 36 = very satisfied.

^g^ 5-point Likert-type agree/disagree scale, where 5 represents highest behaviour change beliefs.

Individual characteristics associated with PA overestimation
------------------------------------------------------------

Logistic regression showed that overestimators were more likely to be in a lower socio-economic category (Table [3](#T3){ref-type="table"}). In particular, the odds of being an overestimator were twice as high among those in routine/manual occupations compared with those in managerial/professional occupations (OR = 2.24, 95% CI = 1.22 to 4.12, *p* = 0.009). None of the other variables were significantly associated with PA overestimation (*p* \> 0.05).

###### 

**Association between physical activity overestimation and socio-demographic, clinical and health behaviour characteristics in the*ADDITION-Plus*cohort, 2003 to 2007**

  **Characteristic**                   **Category/scale, units**      **Overestimators % (N)**   **Univariable OR**^**b**^**(95% CI)**   ***p***   **Multivariable OR**^**c**^**(95% CI)**   ***p***
  ------------------------------------ ------------------------------ -------------------------- --------------------------------------- --------- ----------------------------------------- ---------
  **Socio-demographic**                                                                                                                                                                       
  Sex                                  ♀                              20.7 (33)                  1                                       0.50      1                                         0.70
                                       ♂                              17.7 (47)                  0.84 ( 0.51 to 1.39)                              0.91 (0.54 to 1.52)                        
  Age category                         42--54.9, years                14.1 (13)                  1                                       0.55      1                                         0.51
                                       55--59.9                       18.9 (17)                  1.41 (0.64 to 3.12)                               1.53 (0.69 to 3.43)                        
                                       60--64.9                       22.2 (18)                  1.72 (0.78 to 3.82)                               1\. 77 (0.79 to 3.98)                      
                                       65--71                         19.7 (32)                  1.52 (0.75 to 3.08)                               1.37 (0.66 to 2.81)                        
  Ethnicity                            Asian/Black                    18.2 (2)                   1                                       0.97                                                 
                                       Caucasian                      18.8 (78)                  1.03 (0.21 to 4.97)                                                                          
  Socio-economic category              Managerial/professional        12.9 (22)                  1                                       0.009     1                                          
                                       Intermediate                   21.1 (22)                  1.68 (0.86 to 3.31                                1.69 (0.86 to 3.31)                       0.009
                                       Routine/manual                 24.8 (36)                  2.24 (1.21 to 4.12)                               2.24 (1.22 to 4.12)                        
  **Clinical**                                                                                                                                                                                
  BMI                                  kg/m^2^                        32.6 (4.7)^a^              1.023 (0.98 to 1.07)                    0.33                                                 
  Waist Circumference                  cm                             109.7 (11.0)^a^            1.01 (0.99 to 1.02)                     0.51                                                 
  **Health behaviours**                                                                                                                                                                       
  Smoking status                       Current                        22.4 (13)                  1                                       0.35                                                 
                                       Former                         15.8 (33)                  0.66 (0.32 to 1.38)                                                                          
                                       Never                          21.1 (33)                  0.95 (0.45 to 1.99)                                                                          
  Alcohol consumption                  Units · week^-1^               7.6 (9.4)^a^               1.00 (0.98 to 1.03)                     0.89                                                 
  Dietary intake                       Total energy, Kcal · day^-1^   1727 (484)^a^              1.00 (0.99 to 1.01)                     0.29                                                 
                                       Fat, g · day^-1^               59 (22)^a^                 0.99 (0.98 to 1.01)                     0.76                                                 
                                       Fruit, g · day^-1^             341 (224)^a^               1.00 (0.99 to 1.01)                     0.23                                                 
                                       Vegetables, g · day^-1^        255 (139)^a^               1.00 (0.99 to 1.00)                     0.54                                                 
  **Quality of life and well being**                                                                                                                                                         
  EuroQol EQ-5D                        scale, --0.3 to 1^d^           0.85 (0.2)^a^              1.55 (0.45 to 5.32)                     0.48                                                 
  ADDQoL                               scale, --9 to 9^e^             0.70 (1.0)^a^              0.87 (0.68 to 1.12)                     0.27                                                 
  SF-36 general health                 scale, 1 to 5^f^               2.9 (0.9)^a^               1.10 (0.83 to 1.46)                     0.50                                                 
  Diabetes treatment satisfaction      scale, 0 to 36^g^              30.4 (5.5)^a^              1.01 (0.97 to 1.07)                     0.51                                                 
  **Psychological**                                                                                                                                                                           
  Intention                            scale, 1 to 5^h^               3.6 (0.9)^a^               1.31 (0.95 to 1.82)                     0.10                                                 
  Perceived behavioural control        scale, 1 to 5^h^               3.6 (0.8)^a^               1.09 (0.81 to 1.46)                     0.58                                                 

^a^ Mean characteristic of overestimators (SD).

^b^ Adjusted for age, sex and trial arm.

^c^ Adjusted for age, sex, trial arm and socio-economic category (occupation).

^d^ Weighted health state index, where dead = 0 and full health = 1.

^e^ Weighted impact of diabetes index, where −9 = maximum negative and +9 = maximum positive diabetes impact.

^f^ General health utility scale ranging from 1 = excellent to 5 = poor.

^g^ Diabetes treatment satisfaction scale, where 0 = very dissatisfied and 36 = very satisfied.

^h^ 5-point Likert-type agree/disagree scale, where 5 represents highest behaviour change beliefs.

Excluding individuals with less than 48 hours of Actiheart wear (n = 6), or who reported taking beta-blockers (n = 103) did not change these results (data not shown). After assigning more conservative metabolic costs to occupational activity and re-running our series of regression models (linear and logistic), no qualitative difference in the magnitude or the direction of the regression coefficients or odds ratios were found (data not shown). Self-reported and objectively measured PAEE were significantly positively correlated, even when season of objective measurement was adjusted for (Spearman's correlation coefficients (rho) in men: rho = 0.28, *p* \<0.001 and women: rho = 0.27, *p =* 0.006 adjusted for season). Furthermore, very similar correlations were observed when participants were randomly grouped in season-balanced groups of four; the between-cluster rho for self-reported and objective PAEE was 0.24 and 0.23 in men and women, respectively.

Discussion
==========

To our knowledge, this is the first study to identify characteristics associated with the disparity between objective and self-reported PA on a continuous scale. In this cohort of recently diagnosed T2DM patients from Eastern England, individuals with greater PA disparity were more likely to be male, be in younger age- and lower socio-economic categories and have a lower BMI. Furthermore, when examining the characteristics of those more likely to overestimate their PA (by the PAEE equivalent of 30 minutes of moderate activity per day), overestimators (19%, n = 80) were more likely to be in lower socio-economic categories. Objective PA levels were relatively low in these recently diagnosed T2DM patients. Indeed, compared with a representative sample of 10,000 healthy adults from ten European countries which used the same objective method of assessing PA --- *Interact Study*\[[@B38]\] --- mean objective PAEE levels were 7.9 kJ · kg^-1^ · day^-1^ lower in our population of recently diagnosed T2DM patients (34.4 and 42.3 kJ · kg^-1^ · day, respectively). Differences in population characteristics may explain some of the between-study PAEE differences; for example, here the average age was 60.3 ± 7.5 years, compared to 53.8 ± 9.4 years in *Interact*. Nevertheless, given the benefits of PA for people with diabetes, these data highlight health promotion opportunities in terms of increasing PA levels.

The association between greater PA disparity and low BMI could be partly explained by the observation that those who underestimate their PA level have substantially higher objective PA levels compared to those who are PA overestimators or PA aware. In addition, leaner individuals may spend less time reflecting on their PA levels than more overweight individuals. Individuals with greater PA disparity were more likely to be male, potentially driven by higher male objective PA levels, coupled with gender differences in the ability to self-assess activity levels in the face of gender norms regarding PA. For example, social desirability/approval may influence female self-reported PA more than males. Several factors may contribute to the observation that PA disparity is greater in younger participants. Social approval is associated with PA underestimation \[[@B39]\] and this factor may be more important in younger age groups. Indeed, post-hoc analyses show that underestimation is most prevalent in the youngest age group (data not shown). In addition, our self-report PA measure may not have adequately captured the activity of this age group, also leading to PA underestimation. Occupational PA is a known key determinant of total PA \[[@B37]\]. Thus, inadequate perception of occupational PA in people with routine/manual relative to managerial/professional occupations may help explain the association between socio-economic category and increased PA disparity. An alternative explanation could be that individuals in lower socio-economic categories may experience more difficulty in completing the questionnaire, resulting in higher PA disparity.

Previous studies assessing 'PA awareness' -- the difference between an individual's belief and measured attainment of PA guidelines -- have predominantly relied on self-reported and self-rated assessments. We have extended previous work by incorporating an objective measure of PA, which likely reflects true PA more accurately than self-reported or self-rated PA. The different approaches used to classify PA awareness make it difficult to directly compare proportions and characteristics of PA overestimators and underestimators. Previous studies report a lower proportion of underestimators (ranged from 6.1 to 22.5%) and a slightly higher proportion of overestimators (ranged from 15% and 35%) compared with our study (67% and 19%, respectively), with the remaining individuals falling into two other awareness categories \[[@B11]-[@B14]\]. In this study, the proportions of individuals in the three awareness groups (over- and under-estimator and aware) did not differ by trial arm suggesting that the intervention was not responsible for the large percentage of under estimators. Reasons for the lower proportion of underestimators in prior studies include the fact that the self-reported PA questionnaire captures specific activities over four domains. Thus, inevitably there will be some activities people engage in that are not included in questionnaires and we expect lower total activity levels from these questionnaires, compared to complete 24-hour recall obtained from continuous wear of objective monitors which capture all activity. Furthermore, the method used here to convert self-reported PA into PAEE removes resting metabolic rate (RMR) to produce estimates that better reflect PA in its own right and not total energy expenditure \[[@B40]\]. Studies which include RMR may produce inflated PA estimates. Despite methodological differences, in terms of the characteristics of overestimators, one previous study found individuals with a family history of T2DM are more likely to be overestimators if they are in lower socio-economic categories \[[@B14]\]. An association between PA overestimation and lower BMI has been reported in healthy adults \[[@B11]-[@B13]\] and those at high risk of developing T2DM \[[@B14]\], but similar associations were not shown using PA disparity as an outcome. Further work combining the various awareness measures in one study would be useful.

Strengths and limitations
-------------------------

The strengths of this study include the use of an objective measure of PA and our derivation of a novel continuous measure of PA disparity based on converting objective and self-report measures to the same units. Our method of objectively assessing PA has been validated against indirect calorimetry during simulated daily activities \[[@B41]-[@B43]\] and during free-living against doubly labelled water \[[@B44]\] and likely reflects true PA more accurately than self-report. Use of an objective PA measure to classify PA disparity avoids issues with correlated error arising from use of two self-report measures. Discounting the basal metabolic rate from our self-reported PA data ensures self-reported PA estimates more accurately reflect objective PA. In England, GP registers typically cover \~99% of residents \[[@B45]\] and, as nearly half of GPs approached participated in *ADDITION-Plus,* participants were drawn from a large population-based sample ensuring generalisability to similar locations. Follow-up at one year was also high (93% of living patients).

One limitation of this study is the cross-sectional design which precludes the establishment of causality. Generalisability to ethnically diverse UK populations and/or more deprived areas may be limited due to the recruitment of GPs from a single geographical area, East Anglia England. Observed discrepancies between objective and self-reported PA could partly reflect differences in reference period (4 days for objective and one year for self-reported PA). However, results from sensitivity analyses do not support a major role of between-instrument differences in the time frames captured. Self-reported PA may be underestimated (e.g. if individuals engage in activities that are not listed on the questionnaire) or overestimated (e.g. if the energy costs of activities are overestimated). Indeed, it is possible that assigning MET values to contemporary occupational activities using historical literature overestimated occupational PA in those with routine/manual occupations, which could bias PA disparity with respect to social class (occupationally defined). Sensitivity analyses assigning lower occupational MET values to occupational classes did not alter our findings, suggesting this source of bias is likely to be minimal but cannot be ruled out. Similarly, the scaling of self-reported activity estimates to daily quantities of activity energy expenditure has its limitations, which may be exacerbated by significant proportions of time not accounted for.

What implications do these results have for PA behaviour change interventions? Firstly, given the relatively low level of PA in this sample of individuals with recently diagnosed T2DM, interventions aimed at increasing PA levels are needed and may help improve overall health as well as slow or prevent T2DM progression, as observed in individuals with impaired glucose tolerance \[[@B46]-[@B48]\]. Secondly, as high PA disparity (and poor PA awareness) can reduce the effectiveness of interventions aimed at changing PA intentions and behaviour \[[@B49]\], decreasing PA disparity may play an important role in promoting PA. The proportion of people overestimating their PA observed in this study suggests that improving people's awareness of PA levels may form an important step in interventions aimed at increasing PA. Decreasing PA disparity can be achieved through self-monitoring of, and feedback on PA levels \[[@B50],[@B51]\]. Thirdly, focusing on helping individuals from lower socio-economic categories to become more aware of their PA may be one way of maximising the efficacy of PA interventions.

Conclusions
===========

The low PA levels amongst T2DM patients early in disease progression suggest a need for interventions to increase PA in this group with high, but modifiable risk. The degree of overestimation suggests that decreasing PA disparity and increasing PA awareness might be an important first step in effective PA interventions \[[@B11]\]. PA interventions should be developed for lower socio-economic groups, which comprise a hard-to-reach population in terms of healthcare equity. Strategies for enabling realistic assessment of PA levels through self-monitoring or feedback warrant further investigation and may help refine and target effective PA intervention programmes.
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